# AMONDYS 45

NDC: 60923-227
Generic name: casimersen
Labeler / Manufacturer: Sarepta Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210225

FDA application: NDA213026

## Active ingredients

- CASIMERSEN: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60923-227"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60923-227
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9e5fd44-eeda-4580-bba1-a734828bbcc3